[Featured Stock] BioLeaders Hits Upper Limit with Virus Protection Effectiveness Higher than Pfizer

[Asia Economy Reporter Kwon Jae-hee] BioLeaders recorded a limit-up.

BioLeaders began soaring from the start of trading on the 27th and as of 10:48 AM, it is trading at 13,250 KRW, up 29.90% compared to the previous day.

On this day, BioLeaders announced that its developing "COVID-19 Universal Multivalent Vaccine (BLS-A01)" confirmed high neutralization efficacy in preclinical results. Neutralization refers to the ability to neutralize the virus through neutralizing antibodies, and vaccines showing a neutralizing antibody titer above 1000 are generally evaluated as having a high level of protection against the virus. According to a recent paper published in Nature, the Pfizer vaccine is known to have a neutralizing antibody titer of about 300 to 500 against variant viruses.